The purpose of the work was to conduct a comparative analysis of the quantitative and qualitative composition of the microbiota of the urogenital system in different segments of the population of Dnipro for the period of 1 January - 31 August, 2020. Material and methods. To study the microbial landscape and determine the levels of resistance to antimicrobial drugs variants of microorganisms circulating in the urogenital tract, were examined 176 people of different ages and genders – patients of the Medical Diagnostic Center at the Dnieper Medical Academy (Dnipro) for the period of 1 January - 31 August, 2020. Results and discussion. According to the results of the microbiological study, the fact of development of infectious processes was established in 86 people, which accounted for 32.31% of cases. When studying the microbial landscape of the reproductive system of the examined patients, there was the following spectrum of priority pathogens of urogenital infections: in children and adolescents: Klebsiella oxytoca, Haemophilus influenzae / H. parainfluenzae, Escherichia coli, Streptococcus agalactiae; in women: Candida albicans, Streptococcus agalactiae, Escherichia coli, Ureaplasma spp.; in men: Ureaplasma spp. and Escherichia coli. During the monitoring of the proliferation of antibiotic-resistant variants of microorganisms – pathogens of infectious processes, the highest levels of resistance in isolated clinical isolates in relation to the drugs of classes were established: fluoroquinolons – 29.16%, cephalosporins – 18.75% and carbopenems – 10.42% of cases. Conclusion. With the use of test systems "Femoflor" and "Androflor" the species spectrum of pathogens of dysbiotic conditions of the urogenital tract in 88 patients aged 17-75 years with the help of polymerase chain reaction in real time was investigated. The incidence of detection of conventional pathogenic and pathogenic microorganisms from the urogenital sphere of women and men and the ratio of aerobic and anaerobic microbiota in dysbiotic syndromes is shown. According to the results of the study, 60.97% of women and 76.59% of men had significant deviations toward reducing the titers of representatives of the symbiotic microbiota – bacteria of the genus Lactobacilllus on the background of increasing quantitative indicators of conventional pathogenic microorganisms Gardnerella vaginalis etc., Eubacterium spp., Ureaplasma spp., Candida spp., Anaerococcus spp., Bacteroides spp. etc., Enterobacterium spp., and the presence of pathogenic microorganisms Mycopasma genitalium, Trichomonas vaginalis, Chlamydia trachomatis, Ureaplasma parvum in significant titras

Keywords: urogenital tract, microbiota, antibiotic resistance, real-time polymerase chain reaction

Full text: PDF (Ua) 353K

1. Vyalov SS. Diagnostika i lechenie urogenitalnykh infektsiy v obshchey praktike [Diagnosis and treatment of urogenital infections in general practice]. Arkh vnutr med. 2012; 3(3): 20-6. [Russian]
2. Goncharenko VV. Mikrobiologichniy monitoring infektsiy urogenitalnogo traktu v umovakh venerologichnoyi kliniki [Microbiological monitoring of infections of the urogenital tract in the minds of a venereologic clinic]. Dermatologiya ta venerologiya. 2014; 4(1): 44-53. [Ukrainian]
3. Magistro G, Stief CG. The urinary tract microbiome: the answer to all our open questions? Eur Urol. 2018; 5(1): 36-8. https://doi.org/10.1016/j.euf.2018.06.011
4. Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Castillo E, Del Moral JS, Gómez-Millán J, et al. The Urinary Tract Microbiome in Health and Disease. Eur Urol. 2018; 4(1): 128-38. https://doi.org/10.1016/j.euf.2016.11.001
5. Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract - a role beyond infection. Nat Rev Urol. 2018; 12(1): 81-90. https://doi.org/10.1038/nrurol.2014.361
6. Wolfe AJ, Brubaker L. "Sterile urine" and the presence of bacteria. Eur Urol. 2018; 68(1): 173-4. https://doi.org/10.1016/j.eururo.2015.02.041
7. Brubaker L, Wolfe AJ. The new world of the urinary microbiota in women. Am J Obstet Gynecol. 2015; 213(1): 644-9. https://doi.org/10.1016/j.ajog.2015.05.032
8. Schneeweiss J, Koch M, Umek W. The human urinary microbiome and how it relates to urogynecology. Int Urogynecol J. 2016; 27(1): 1307-12. https://doi.org/10.1007/s00192-016-2944-5
9. Radzinskiy VE, Khamoshina MB, Kaygorodova LA. Korrektsiya narusheniy biotsenoza vlagalishcha - marsh na meste ili dvizhenie vpered? [Correction of violations of the vaginal biocenosis - marching in place or moving forward?]. Reproduktivnaya endokrinologiya. 2014; 4(18): 92-100. [Russian]
10. Gottschick C, Deng ZL, Masur C, Abels C, Pieper DH, Wagner-Döbler I. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment. Microbiome. 2017; 5 (99): 1-15. https://doi.org/10.1186/s40168-017-0305-3
11. Bao Y, Al KF, Chanyi RM, Whiteside S, Dewar M, Razvi H, et al. Questions and challenges associated with studying the microbiome of the urinary tract. Ann Transl Med. 2017; 5(2): 33-6. https://doi.org/10.21037/atm.2016.12.14
12. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015; 109(1): 309-18. https://doi.org/10.1179/2047773215Y.0000000030
13. Richard JF, Yitzhak T. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014; 6(1): 25-64. https://doi.org/10.4137/PMC.S14459
14. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clinical Infect Dis. 2003; 36(1): 1433-7. https://doi.org/10.1086/375081
15. Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016; 22(1): 416-22. https://doi.org/10.1016/j.cmi.2015.12.002
16. Yusuf EO, Kemjou TS. Antibiotic resistance among genital tract isolates from sexually-transimitted disease patients. Med Lab Sci J. 2005; 14(1): 63-8. https://doi.org/10.4314/jmls.v14i1.35321
17. Amin ET, Njumkeng C, Kika BT, Fualefac A, Njukeng P. Pattern of antimicrobial resistance among bacterial isolates from urogenital clinical specimens: a descriptive study from the Buea Health District, Cameroon. Drugs-Real World Outcomes. 2018; 5(1): 101-8. https://doi.org/10.1007/s40801-018-0132-2
18. Rampersaud R, Randis TM, Ratner AJ. Microbiota of the upper and lower genital tract. Semin. Fetal Neonatal Med. 2012; 17(1): 51-7. https://doi.org/10.1016/j.siny.2011.08.006
19. Moreno I, Simon C. Deciphering the effect of reproductive tract microbiota on human reproduction. Reprod Med Biol. 2019; 18(1): 40-50. https://doi.org/10.1002/rmb2.12249
20. Franasiak JM, Scott RT. Introduction: microbiome in human reproduction. Fertil Steril. 2015; 104(6): 1341-3. https://doi.org/10.1016/j.fertnstert.2015.10.021
21. Franasiak JM, Scott RT. Reproductive tract microbiome in assisted reproductive technologies. Fertil Steril. 2015; 104(6): 1364-71. https://doi.org/10.1016/j.fertnstert.2015.10.012
22. Whitman WB, Holt JG. Bergey's manual of systematic bacteriology. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2000. 787 p.
23. CLSI. Performance standards for antimicrobial susceptibility testing. 30th ed. Wayne PA: Clinical and Laboratory Standards Institute; 2019. 332 p.
24. American Society for Microbiology. ASM style manual for journals and books. Washington, DC: American Society for Microbiology; 1985. 190 p.
25. Naber KG, Holfstetter A. Recommended standards in diagnosis and therapy of urinary tract infections. Eur Urol. 1998; 34(1): 1-6.
26. Reid G, Brigidi P, Burton JP, Contractor N, Duncan S, Fargier E, et al. Microbes central to human reproduction. Am J Reprod Immunol. 2015; 73(1): 1-11. https://doi.org/10.1111/aji.12319
27. Peric A, Weiss J, Vulliemoz N, Baud D, Stojanov M. Bacterial Colonization of the Female Upper Genital Tract. International Journal of Molecular Sciences. 2019; 20(14): 34-45. https://doi.org/10.3390/ijms20143405
28. Linhares IM, Witkin SS, Giraldo P. Bacterial flora of the female genital tract: function and immune regulation. Best Pract Res Clin Obstet Gynaecol. 2007; 21(1): 347-54. https://doi.org/10.1016/j.bpobgyn.2006.12.004
29. Witkin SS. The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth. Best Pract Res Clin Obstet Gynaecol. 2015; 122(2): 213-8. https://doi.org/10.1111/1471-0528.13115
30. Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome. 2015; 3(31): 123-8. https://doi.org/10.1186/s40168-015-0094-5
31. Dasari S, Anandan SK, Rajendra W, Valluru L. Role of microbial flora in female genital tract: a comprehensive review. Asian Pacific J Trop Dis. 2016; 6(6): 909-17. https://doi.org/10.1016/S2222-1808(16)61155-6
32. Mändar R. Microbiota of male genital tract: impact on the health of man and his partner. Pharmacol Res. 2013; 69(11): 32-41. https://doi.org/10.1016/j.phrs.2012.10.019
33. De Francesco MA, Negrini R, Ravizzola G, Galli P, Manca N. Bacterial species present in the lower male genital tract: a fiveyear retrospective study. Eur J Contracept Reprod Health Care. 2011; 16(1): 47- 53. https://doi.org/10.3109/13625187.2010.533219
34. Askienazy-Elbhar M. Male genital tract infection: the point of view of the bacteriologist. Gynecol Obstet Fertil. 2005; 33(9): 691-7. https://doi.org/10.1016/j.gyobfe.2005.07.008
35. Purvis K, Christiansen E. Infection in the male reproductive tract. Impact, diagnosis and treatment in relation to male infertility. Int J Androl. 2020; 16(1): 1-13. https://doi.org/10.1111/j.1365-2605.1993.tb01146.x
36. Carlet J, Pulcini C, Piddock LJV. Antibiotic resistance: A geopolitical issue. Clin Microbiol Infect. 2014; 20(10): 949-53. https://doi.org/10.1111/1469-0691.12767
37. Opal SM. Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance. Crit Care. 2016; 20(1): 10-2. https://doi.org/10.1186/s13054-016-1549-1
38. Hulscher ME, Grol RP, Vandermeer JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010; 10(3): 167-75. https://doi.org/10.1016/S1473-3099(10)70027-X
39. Bondar MV, Pilipenko MM, Svintukovskiy MYu, Kharchenko LA, Previsla OM, Tsvik IM. Antibiotikorezistentnist mikroorganizmiv: mekhanizmi rozvitku y shlyakhi zapobigannya [Antibiotic-resistant microorganism: mechanisms of development and paths for getting rid of]. Meditsina neotlozhnykh sostoyaniy. 2016; 3(3): 11-7. [Ukrainian] https://doi.org/10.22141/2224-0586.3.74.2016.76136
40. Andrukh VS, Andrukh VN. Antibiotiki i antibiotikorezistentnist: problemi i shlyakhi virishennnya [Antibiotics and antibiotic resistance: problems and ways of life]. Dityachiy likar. 2017; 4(4): 32-6. [Ukrainian]
41. Gumenyuk MI, Denisov OS, Feshchenko YuI. Antibiotikorezistentnist mikroorganizmiv. Stan problemi ta shlyakhi virishennya [Antibiotic-resistant microorganisms. Problem status and solutions]. Ukrayinskiy khimioterapevtichniy zhurnal. 2010; 1(23): 4-10. [Ukrainian]
42. Supotnitskiy MV. Mekhanizmy razvitiya rezistentnosti k antibiotikam u bakteriy [Mechanisms for the development of antibiotic resistance in bacteria]. Biopreparaty. 2011; 2(2): 4-44. [Russian]
43. Komolafe OO. Antibiotic resistance in bacteria - an emerging public health problem. Malawi Med J. 2003;15(2): 63-7. https://doi.org/10.4314/mmj.v15i2.10780
44. Amyes SGB. The rise in bacterial resistance. Brit Med J. 2000; 320(10): 199-200. https://doi.org/10.1136/bmj.320.7229.199
45. Laxminarayan R. Antibiotic resistance: the need for global solutions. Lancet Infect Dis. 2013; 13(12): 1057-98. https://doi.org/10.1016/S1473-3099(13)70318-9
46. Malik B, Bhattacharyya S. Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse. Sci Rep. 2019; 9(1): 151-84. https://doi.org/10.1038/s41598-019-46078-y
47. Martínez JL, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev. 2018; 15(4): 647-79. https://doi.org/10.1128/CMR.15.4.647-679.2002
48. Gergova RT, Strateva TV, Mitov IG. Gardnerella vaginalis-associated bacterial vaginosis in Bulgarian women. The Brazilian Journal of Infectious Diseases. 2013; 17(3): 307-13. https://doi.org/10.1016/j.bjid.2012.10.026
49. Teixeira GS, Carvalho FP, Arantes RM, Nunes AC, Moreira JL, Mendonca M, et al. Characteristics of Lactobacillus and Gardnerella vaginalis from women with or without bacterial vaginosis and their relationships in gnotobiotic mice. J Med Microbiol. 2012; 61(1): 1074-81. https://doi.org/10.1099/jmm.0.041962-0
50. Janulaitiene M, Paliulyte V, Grinceviciene S, Zakareviciene J, Vladisauskiene A, Marcinkute A, et al. Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis. BMC Infect Dis. 2017; 17(1): 389-94. https://doi.org/10.1186/s12879-017-2501-y
51. Gruzevsky OA, Vladimirova MP. The results of a complex bacteriological study of vaginal contents under the conditions of bacterial vaginosis. Advances in biology and medicine. 2014; 2(2): 54-7.
52. Manzoor S, Aziz M, Sheikh AS. Identification and Characterization of Candida on CHROM Agar™ in Pregnant Women of Multan, Pakistan. J Women's Health Care. 2018; 7(1): 2-8. https://doi.org/10.4172/2167-0420.1000424
53. Okodo M, Kawamura J, Okayama K, Kawai K, Fukui T, Shiina N, et al. Cytological features associated with ureaplasma urealyticum in pap cervical smear. Asian Pac J Cancer Prev. 2017; 18(8): 2239-42.
54. Kiessling AA, Desmarais BM, Yin HZ, Loverde JJ, Eyre RC. Detection and identification of bacterial DNA in semen. Fertility and Sterility. 2008; 90(5): 1744-56. https://doi.org/10.1016/j.fertnstert.2007.08.083